A detailed history of Abrdn PLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Abrdn PLC holds 1,362,316 shares of AZN stock, worth $87.8 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,362,316
Previous 1,506,523 9.57%
Holding current value
$87.8 Million
Previous $117 Million 9.65%
% of portfolio
0.2%
Previous 0.23%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$76.67 - $87.62 $11.1 Million - $12.6 Million
-144,207 Reduced 9.57%
1,362,316 $106 Million
Q2 2024

Aug 09, 2024

BUY
$66.81 - $80.83 $697,964 - $844,431
10,447 Added 0.7%
1,506,523 $117 Million
Q1 2024

May 08, 2024

BUY
$61.03 - $69.57 $4.59 Million - $5.23 Million
75,200 Added 5.29%
1,496,076 $101 Million
Q4 2023

Jan 31, 2024

BUY
$61.89 - $69.28 $68.2 Million - $76.4 Million
1,102,490 Added 346.27%
1,420,876 $95.7 Million
Q3 2023

Nov 06, 2023

BUY
$64.85 - $71.7 $103,759 - $114,720
1,600 Added 0.51%
318,386 $21.6 Million
Q2 2023

Jun 20, 2024

SELL
$69.91 - $75.81 $69,910 - $75,810
-1,000 Reduced 0.31%
316,786 $22.7 Million
Q2 2023

Aug 04, 2023

SELL
$69.91 - $75.81 $69,910 - $75,810
-1,000 Reduced 0.31%
316,786 $22.7 Million
Q1 2023

Jun 20, 2024

BUY
$63.15 - $71.6 $1.32 Million - $1.5 Million
20,900 Added 7.04%
317,786 $22.1 Million
Q1 2023

Apr 28, 2023

BUY
$63.15 - $71.6 $1.32 Million - $1.5 Million
20,900 Added 7.04%
317,786 $22.1 Million
Q4 2022

Jun 20, 2024

SELL
$54.21 - $70.44 $65 Million - $84.5 Million
-1,199,190 Reduced 80.16%
296,886 $20.1 Million
Q2 2022

Aug 05, 2022

SELL
$59.26 - $71.14 $1.76 Million - $2.11 Million
-29,709 Reduced 9.1%
296,886 $19.6 Million
Q1 2022

May 04, 2022

SELL
$55.72 - $67.12 $2.16 Million - $2.6 Million
-38,800 Reduced 10.62%
326,595 $21.7 Million
Q4 2021

Feb 08, 2022

SELL
$54.02 - $63.83 $1.65 Million - $1.95 Million
-30,500 Reduced 7.7%
365,395 $21.3 Million
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $1.37 Million - $1.5 Million
24,640 Added 6.64%
395,895 $23.8 Million
Q2 2021

Aug 10, 2021

BUY
$48.42 - $60.18 $547,146 - $680,034
11,300 Added 3.14%
371,255 $22.2 Million
Q1 2021

May 06, 2021

BUY
$47.16 - $54.44 $56,591 - $65,328
1,200 Added 0.33%
359,955 $17.9 Million
Q4 2020

Feb 10, 2021

BUY
$48.52 - $58.02 $4.32 Million - $5.17 Million
89,055 Added 33.02%
358,755 $17.9 Million
Q3 2020

Oct 21, 2020

SELL
$53.07 - $61.1 $95,526 - $109,980
-1,800 Reduced 0.66%
269,700 $14.8 Million
Q1 2020

May 13, 2020

BUY
$37.79 - $51.33 $10.3 Million - $13.9 Million
271,500 New
271,500 $12.1 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.